2 While serving as environmental reservoir for V. cholerae infection, biofilms are also crucial for 3 intestinal colonization of the pathogen. Triterpenoids, a group of bioactive phytochemicals, have 4 been tested for antibiofilm activity against model biofilm forming bacteria in recent times. In this 5 context, glycyrrhetinic acid (GRA), ursolic acid (UA) and betulinic acid (BA), representing three 6 categorically distinct groups of pentacyclic triterpenoids, are targeted for profiling their impact 7 on Vibrio cholerae C6709 biofilms. The triterpenoids substantially affected biofilm associated 8 attributes like formation, substratum adherence and dispersion from preformed biofilms. Though 9 at variable degree, the compounds decreased cell surface hydrophobicity and composition in 10 terms of macromolecular content. Not only EPS-associated extracellular enzyme activities were 11 estimated to be reduced by triterpenoid exposure, ultra structural analysis also revealed that 12 GRA, UA and BA can affect extracellular polymeric substance (EPS) content. Albeit total 13 extracellular proteolytic activity remained unaffected by the triterpenoids, GRA treatment 14 resulted in considerable reduction of extracellular gelatinase activity. Molecular docking analysis 15 indicated potential interaction with cyclic di-GMP sensor VpsT, autoinducer-2 sensor kinase 16 LuxP-LuxQ and transcriptional activator HapR, component of complex quorum sensing 17 networks modulating biofilm formation. Comprehensive analysis of antibiotic action revealed 18 accentuation of cephalosporin antibiotics with GRA and UA while BA potentiated action of 19 fluoroquinolones, widening the scope of combinatorial therapeutic strategy.
organisms (Mourino-Perez et al., 2003) . Deciphering the molecular mechanism for biofilm 1 development identified VpsR and cyclic-di-GMP mediated pathways as the key modulators in V. 2 cholerae (Hsieh et al., 2018) . Biofilm formation by the pathogen is directly linked to its 3 pathogenesis (Silva and Benitez, 2016) and increased antibiotic resistance has been shown in Materials and methods 1 Selection of representative triterpenoid, bacterial strains and growth condition 2 Representative triterpenoids from each of the three major groups, namely betulinic acid (BA) 3 from lupine; glycyrrhetinic acid (GA) from β-amyrin and ursolic acid (UA) (Sigma) from ursane 4 families of triterpenoids were selected. For the studies batch cultures of Vibrio cholarae C6709 5 strains (bacterium O1, biotype El tor, serotype Inaba) were grown at 37°C with shaking in 6 Luria-Bertani (LB) or Mueller-Hinton medium (for antibiotic assays). Swarming motility assay 7 was carried out in LB medium supplemented with 0.5% agar, as described elsewhere (Rashid et 8 al., 2000). Biofilms were allowed to form into borosilicate glass test-tubes after an incubation of 24 h at 18 37°C. The tubes were then rinsed with distilled water and filled with crystal violet stain. After 5 19 min, the tubes were rinsed. The biofilm-associated crystal violet was suspended with ethanol 20 (70%), and the optical density (OD) of the resulting suspension was measured. Biofilm-Dispersion assay 23 Biofilms were grown for 24 hrs in the LB medium. Aged medium was replaced with fresh 1 medium containing phytochemicals to induce biofilm dispersion that was measured by an 2 increase in turbidity for media at 600 nm. 3 4 Microscopic examination of integrity of Biofilms 5 The biofilm integrity was examined for detecting minute alterations in matrix structure by 6 scanning electron microscopy (SEM).
7
Autoaggregation assay 8 Bacteria were grown at 37°C for 24h in LB broth. The cells were harvested by centrifugation and 9 suspended in PBS to 0·5 OD units at 600nm. 2 ml bacterial suspension was placed in each tube, 10 centrifuged and then resuspended in PBS along with the triterpenoids. After 2-3h exposure at 11 37°C, 1 ml of the upper suspension was transferred to another tube and the OD was measured.
12
Aggregation was expressed as 1−(OD upper suspension /OD total bacterial suspension )×100.
13

EPS extraction and assay 14
To investigate EPS composition and properties, V. cholerae strains were cultivated as agar-15 grown biofilms at 37ºC for 24 h. After carefully scraping the bacterial biomass from the agar 16 surface and suspending in NaCl, the cells were dispersed by vigorous stirring followed by high-
17
speed centrifugation to separate it from the EPS. The supernatant was filtered through cellulose 18 acetate membranes to remove residual bacteria and yield a cell-free EPS solution.
19
Chemical composition analysis 20 The major structural groups of the partially purified EPS were detected in absorption mode with 21 Fourier-transformed infrared (FT-IR) spectroscopy using FTIR spectrometer Perkin-Elmer
22
Spectrum 100 and the spectra were obtained in the wave number range of 1000-3500 cm−1 using 23 Spectrum software. Total protein content was measured by adding trichloroacetic acid (TCA) 1 (final concentration, 12%) to the EPS solution, incubating the mixture on ice for 30 min before 2 centrifugation at 13000 rpm for 20 min. The TCA precipitates were washed twice with 10 ml 3 acetone and resuspended in 2 ml of 2-N-morpholinoethanesulfonic acid (MES) buffer (pH 5.0). 4 The protein content was measured using the Bradford assay with bovine serum albumin (BSA) 5 as the calibration standard. subsequently at room temperature for 10 min, the OD of the solution was measured at 420 nm.
19
Antibiotic sensitivity assay, MIC Determination and viability of biofilms 20 Susceptibility to antimicrobial agents was determined by the disc (Himedia) diffusion method 21 according to the CLSI (The Clinical and Laboratory Standards Institute) guidelines. A number of 22 disc concentrations were used to measure the zones of inhibition after 18 to 24 hrs of incubation 23 at 37°C. Antibiotics indicating interaction with triterpenoids were used for MIC determination 1 using standard protocol. Preformed biofilms exposed to triterpenoids were treated with specific 2 antibiotics at 1X MIC concentration. CFU for the biofilms were enumerated by resuspending the 3 film and plating on antibiotic/ triterpenoid free medium. 4 Assaying EPS associated enzyme activities 5 Phosphatase specific activity was measured by the release of p-nitrophenol (PNP) from p-6 nitrophenyl phosphate as described previously ( Prior to determining the impact on biofilm formation, MBC for the triterpenoids were 4 determined. Log-phase bacterial cells (OD ~ 0.6) was exposed to the phytochemicals for 5 concentration range of 0 to 1000 μg/ ml. concentrations, GRA and UA demonstrated reduction in biofilm formation around 3-fold for 800 23 μg/ ml and 400 μg/ ml respectively (P<0.001), however at 400 μg/ ml, BA enhanced biofilm showed ~2-fold reduction for each of the treatments compared to untreated controls, primarily 20 indicating depletion of glycolipid content (Fig. 4D ). The amount of extracellular DNA, which To attain a deeper insight into the impact of the triterpenoids on biofilm physiology, EPS-7 associated enzyme activity was profiled. GRA, UA or BA were found to substantially diminish 8 the phosphatase activity in the EPS preparations ( Fig. 5B ). Extracellular lipase activity was also 9 assayed using para-nitrophenylpalmitate as substrate. UA (100µg/ ml) resulted in significant 10 reduction of lipase activity (2.2-fold). BA (100µg/ ml) also resulted in statistically significant 11 decrease in lipase activity (Fig. 5C ). The triterpenoids seemed not to affect EPS associated 12 protease activity as reflected by azocasein hydrolysis based assay (Fig. 5D ). However when the 13 assay was performed on gelatin agar plate, GRA was found to reduce gelatinase activity by 2-14 fold (P<0.05). UA and BA did not exhibit significant impact on gelatinase activity of the EPS 15 preparations (Fig. 5E ). 16 Since antibiofilm agents are often associated with enhancement of antibiotic action against 17 bacterial biofilms, interaction between the triterpenoids and series of antibiotics were studied.
18
For preliminary screening of antibiotic-triterpenoid interaction, conventional Kirby-Bauer 19 method for determining antibiotic responsiveness was adopted with discs adsorbed with various 20 antibiotics on plates with or without triterpenoids. While BA was found to augment action of two 21 antibiotics from fluoroquinolone family, namely ofloxacin and ciprofloxacin, GRA and UA 22 significantly enhanced inhibitory potential of representatives from cephalosporin group, namely 23 cefotaxime, cefepime and ceftriaxone (Tables S2 and S3 and Fig. 6A ).To test whether presence 1 of the triterpenoid can indeed affect antimicrobial potential against planktonic cells, MIC for the 2 antibiotics and antibiotic-triterpenoid combinations (ofloxacin and ofloxacin with BA; 3 Ciprofloxacin and ciprofloxacin with BA and cefepime, cefotaxim and ceftriaxone with or 4 without UA or GRA independently) were determined by both macrodilution and microdilution. 5 Considerable impact on MIC was determined for UA as cefepime, cephtriaxone and cefotaxim 6 showed reduction of 2, 2.2 and 1.8-fold respectively. GRA displayed lesser impact on the MIC 7 of the antibiotics (Figs. 6B and 6C). As depicted in Fig. 6D , the MIC for ciprofloxacin and 8 ofloxacin was reduced by 1.5 fold when exposed in presence of BA. To explore if such 9 interactions are indeed translated in the action of the antibiotics against biofilmed C6709 cells, 10 cefotaxim was selected for possible interaction with GRA (400 µg/ ml) and UA (200 µg/ ml) 11 while ciprofloxacin was studied for possible interaction with BA (200 µg/ ml). Preformed 12 biofilms were exposed to the antibiotics at various concentrations in combination with respective 13 triterpenoids and CFU for each of the exposed combinations were determined. UA appeared to 14 enhance antibiotic mediated killing effectively at all the tested cefotaxim concentrations with 15 4.75, 5.6 and 9.0-fold reduction in CFU values at 2.5, 5 and 10 µg/ ml respectively. For GRA- 16 cefotaxim combination significant impact was detected at 10 µg/ ml with 6.7-fold reduction in 17 CFU count ( Figs. 6E and 6F ). BA-ciprofloxacin combination showed 3-4-fold reduction in CFU 18 counts at all the tested concentrations of ciprofloxacin (0.5, 1.0 and 2.0 µg/ ml) ( Fig. 6G ). With 19 an objective to validate candidate antibiotic-triterpenoid combinations, we profiled the impact of 20 GRA, UA and BA on responsiveness of a series of antibiotics against planktonic cells. Although and developing an optimal triterpenoid-antibiotic composition can lead to development of 21 combinatorial therapeutics exploiting these bioactive molecules. Over all, comprehensive understanding of anti-biofilm potential of pentacyclic triterpenoids can offer the scope of 1 developing multi-faceted strategies to combat bacterial infections. Koo, H., Allan, R.N., Howlin, R.P., Stoodley, P., Hall-Stoodley, L., 2017. Targeting microbial biofilms: 3 current and prospective therapeutic strategies. Nature reviews. Microbiology 15, 740-755. 4 Krasteva, P.V., Fong, J.C., Shikuma, N.J., Beyhan, S., Navarro, M.V., Yildiz, F.H., Sondermann, H., 2010. 5
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Legends to figures
22
Viability of biofilmed cells were enumerated by determining CFU of biofilms exposed to 23 cefotaxim-GRA (400 μg/ ml) (E); cefotaxim-UA (200 μg/ ml) (F) and ciprofloxacin-BA (200 µg/ 24 ml) (G) combinations. Data are representative of at least three independent replicates. *P < 0.05; 25 **P < 0.01; ***P < 0.001, two tailed unpaired student t-test. Table 1 Determining the test concentrations on the basis of MBC value for test-compounds. 
